Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 2001, p. 3334-3340, Vol. 45, No. 12
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.12.3334-3340.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Antimicrobial Susceptibilities of 1,684 Streptococcus
pneumoniae and 2,039 Streptococcus pyogenes
Isolates and Their Ecological Relationships: Results of a 1-Year
(1998-1999) Multicenter Surveillance Study in Spain
E.
Pérez-Trallero,1
C.
Fernández-Mazarrasa,2
C.
García-Rey,3
E.
Bouza,4
L.
Aguilar,3,*
J.
García-de-Lomas,5
F.
Baquero,6 and
The
Spanish Surveillance Group for Respiratory
Pathogens
Microbiology Department, Hospital Donostia,
San Sebastián,1 Microbiology
Department, Residencia Marqués de Valdecilla,
Santander,2 Medical Department,
GlaxoSmithKline, Tres Cantos,3
Microbiology Department, Hospital General Universitario
Gregorio Marañón,4 and
Microbiology Department, Hospital Ramón y
Cajal,6 Madrid, and Instituto Valenciano
de Microbiología, Valencia,5 Spain
Received 27 September 2000/Returned for modification 30 April
2001/Accepted 26 July 2001
A nationwide multicenter susceptibility surveillance study
which included 1,684 Streptococcus pneumoniae and 2,039 S. pyogenes isolates was carried out over 1 year in order
to assess the current resistance patterns for the two most important
gram-positive microorganisms responsible for community-acquired
infections in Spain. Susceptibility testing was done by a broth
microdilution method according to National Committee for Clinical
Laboratory Standards M100-S10 interpretative criteria. For
S. pneumoniae, the prevalences of highly resistant strains
were 5% for amoxicillin and amoxicillin-clavulanic acid; 7% for
cefotaxime; 22% for penicillin; 31% for cefuroxime; 35% for
erythromycin, clarithromycin, and azithromycin; and 42% for cefaclor.
For S. pyogenes, the prevalence of erythromycin resistance
was 20%. Efflux was encountered in 90% of S. pyogenes and
5% of S. pneumoniae isolates that exhibited erythromycin
resistance. Erythromycin resistance was associated with
clarithromycin and azithromycin in both species, regardless of
phenotype. Despite the different nature of the mechanisms of
resistance, a positive correlation (r = 0.612) between
the two species in the prevalence of erythromycin resistance was found
in site-by-site comparisons, suggesting some kind of link with
antibiotic consumption. Regarding ciprofloxacin, the MIC was
4
µg/ml for 7% of S. pneumoniae and 3.5% of S. pyogenes isolates. Ciprofloxacin resistance (MIC,
4 µg/ml)
was significantly (P < 0.05) associated with
macrolide resistance in both S. pyogenes and S. pneumoniae and with penicillin nonsusceptibility in S. pneumoniae.
*
Corresponding author. Mailing address: Medical
Department, GlaxoSmithKline, c/Doctor Severo Ochoa, 2, Parque
Tecnologico de Madrid, 28760 Tres Cantos, Madrid, Spain. Phone:
34 91 807 5912. Fax: 34 91 807 0596. E-mail:
lorenzo.aguilar-alfaro{at}gsk.com.

The members of the Spanish Surveillance Group for Respiratory
Pathogens are listed in the appendix.
Antimicrobial Agents and Chemotherapy, December 2001, p. 3334-3340, Vol. 45, No. 12
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.12.3334-3340.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Soriano, F., Cafini, F., Aguilar, L., Tarrago, D., Alou, L., Gimenez, M.-J., Gracia, M., Ponte, M.-C., Leu, D., Pana, M., Letowska, I., Fenoll, A.
(2008). Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness. J Antimicrob Chemother
62: 1234-1240
[Abstract]
[Full Text]
-
Okumura, R., Hirata, T., Onodera, Y., Hoshino, K., Otani, T., Yamamoto, T.
(2008). Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae. J Antimicrob Chemother
62: 98-104
[Abstract]
[Full Text]
-
Smith, K., Ednie, L. M., Appelbaum, P. C., Hawser, S., Lociuro, S.
(2008). Antistreptococcal Activity of AR-709 Compared to That of Other Agents. Antimicrob. Agents Chemother.
52: 2279-2282
[Abstract]
[Full Text]
-
de Cueto, M., Rodriguez, J. M., Soriano, M. J., Lopez-Cerero, L., Venero, J., Pascual, A.
(2008). Fatal Levofloxacin Failure in Treatment of a Bacteremic Patient Infected with Streptococcus pneumoniae with a Preexisting parC Mutation. J. Clin. Microbiol.
46: 1558-1560
[Abstract]
[Full Text]
-
Billal, D. S., Fedorko, D. P., Yan, S. S., Hotomi, M., Fujihara, K., Nelson, N., Yamanaka, N.
(2007). In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types. J Antimicrob Chemother
59: 28-34
[Abstract]
[Full Text]
-
Haenni, M., Moreillon, P.
(2006). Mutations in Penicillin-Binding Protein (PBP) Genes and in Non-PBP Genes during Selection of Penicillin-Resistant Streptococcus gordonii. Antimicrob. Agents Chemother.
50: 4053-4061
[Abstract]
[Full Text]
-
Robinson, D. A., Sutcliffe, J. A., Tewodros, W., Manoharan, A., Bessen, D. E.
(2006). Evolution and global dissemination of macrolide-resistant group a streptococci.. Antimicrob. Agents Chemother.
50: 2903-2911
[Abstract]
[Full Text]
-
Amezaga, M. R., McKenzie, H.
(2006). Molecular epidemiology of macrolide resistance in {beta}-haemolytic streptococci of Lancefield groups A, B, C and G and evidence for a new mef element in group G streptococci that carries allelic variants of mef and msr(D). J Antimicrob Chemother
57: 443-449
[Abstract]
[Full Text]
-
Siquier, B., Sanchez-Alvarez, J., Garcia-Mendez, E., Sabria, M., Santos, J., Pallares, R., Twynholm, M., Dal-Re, R., on behalf of the 620 Clinical Study Group,
(2006). Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother
57: 536-545
[Abstract]
[Full Text]
-
Cafini, F., del Campo, R., Alou, L., Sevillano, D., Morosini, M. I., Baquero, F., Prieto, J., on behalf of the Spanish Pneumococcal Network (G03,
(2006). Alterations of the penicillin-binding proteins and murM alleles of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillin in Spain. J Antimicrob Chemother
57: 224-229
[Abstract]
[Full Text]
-
Haller, M., Fluegge, K., Arri, S. J., Adams, B., Berner, R.
(2005). Association between Resistance to Erythromycin and the Presence of the Fibronectin Binding Protein F1 Gene, prtF1, in Streptococcus pyogenes Isolates from German Pediatric Patients. Antimicrob. Agents Chemother.
49: 2990-2993
[Abstract]
[Full Text]
-
Perez-Trallero, E., Garcia-de-la-Fuente, C., Garcia-Rey, C., Baquero, F., Aguilar, L., Dal-Re, R., Garcia-de-Lomas, J., the Spanish Surveillance Group for Respiratory Pat,
(2005). Geographical and Ecological Analysis of Resistance, Coresistance, and Coupled Resistance to Antimicrobials in Respiratory Pathogenic Bacteria in Spain. Antimicrob. Agents Chemother.
49: 1965-1972
[Abstract]
[Full Text]
-
Powis, J., McGeer, A., Duncan, C., Goren, R., de Azavedo, J. C. S., Bast, D. J., Pong-Porter, S., Mazzulli, T., Green, K., Willey, B., Low, D. E.
(2005). Prevalence and Characterization of Invasive Isolates of Streptococcus pyogenes with Reduced Susceptibility to Fluoroquinolones. Antimicrob. Agents Chemother.
49: 2130-2132
[Abstract]
[Full Text]
-
Alonso, R., Mateo, E., Galimand, M., Garaizar, J., Courvalin, P., Cisterna, R.
(2005). Clonal Spread of Pediatric Isolates of Ciprofloxacin-Resistant, emm Type 6 Streptococcus pyogenes. J. Clin. Microbiol.
43: 2492-2493
[Abstract]
[Full Text]
-
Alou, L., Aguilar, L., Sevillano, D., Gimenez, M.-J., Laguna, B., Echeverria, O., Carcas, A., Lubomirov, R., Casal, J., Prieto, J.
(2005). Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers. J Antimicrob Chemother
55: 742-747
[Abstract]
[Full Text]
-
Gracia, M., Martinez-Marin, C., Huelves, L., Gimenez, M. J., Aguilar, L., Carcas, A., Ponte, C., Soriano, F.
(2005). Pulmonary Damage and Bacterial Load in Assessment of the Efficacy of Simulated Human Treatment-Like Amoxicillin (2,000 Milligrams) Therapy of Experimental Pneumococcal Pneumonia Caused by Strains for Which Amoxicillin MICs Differ. Antimicrob. Agents Chemother.
49: 996-1001
[Abstract]
[Full Text]
-
Reinert, R. R., Ringelstein, A., van der Linden, M., Cil, M. Y., Al-Lahham, A., Schmitz, F.-J.
(2005). Molecular Epidemiology of Macrolide-Resistant Streptococcus pneumoniae Isolates in Europe. J. Clin. Microbiol.
43: 1294-1300
[Abstract]
[Full Text]
-
Alberti, S., Garcia-Rey, C., Garcia-Laorden, M. I., Dal-Re, R., Garcia-de-Lomas, J., the Spanish Surveillance Group for Respiratory Pat,
(2005). Survey of emm-Like Gene Sequences from Pharyngeal Isolates of Group C and Group G Streptococci Collected in Spain. J. Clin. Microbiol.
43: 1433-1436
[Abstract]
[Full Text]
-
Alberti, S., Cortes, G., Garcia-Rey, C., Rubio, C., Baquero, F., Garcia-Rodriguez, J. A., Bouza, E., Aguilar, L., the Spanish Surveillance Group for Respiratory Pat,
(2005). Streptococcus pyogenes Pharyngeal Isolates with Reduced Susceptibility to Ciprofloxacin in Spain: Mechanisms of Resistance and Clonal Diversity. Antimicrob. Agents Chemother.
49: 418-420
[Abstract]
[Full Text]
-
Oteo, J., Lazaro, E., de Abajo, F. J., Baquero, F., Campos, J., Spanish Members of the European Antimicrobial Resi,
(2004). Trends in Antimicrobial Resistance in 1,968 Invasive Streptococcus pneumoniae Strains Isolated in Spanish Hospitals (2001 to 2003): Decreasing Penicillin Resistance in Children's Isolates. J. Clin. Microbiol.
42: 5571-5577
[Abstract]
[Full Text]
-
Tarrago, D., Aguilar, L., Gimenez, M. J., Fenoll, A., Casal, J.
(2004). Effects of Amoxicillin Subinhibitory Concentrations on the Cross-Protection Developed by Pneumococcal Antibodies in Mouse Sepsis Caused by an Amoxicillin-Resistant Serotype 6B Streptococcus pneumoniae Strain. Antimicrob. Agents Chemother.
48: 4144-4147
[Abstract]
[Full Text]
-
Tiemei, Z., Xiangqun, F., Youning, L.
(2004). Resistance Phenotypes and Genotypes of Erythromycin-Resistant Streptococcus pneumoniae Isolates in Beijing and Shenyang, China. Antimicrob. Agents Chemother.
48: 4040-4041
[Abstract]
[Full Text]
-
Falco, V., Almirante, B., Jordano, Q., Calonge, L., del Valle, O., Pigrau, C., Planes, A. M., Gavalda, J., Pahissa, A.
(2004). Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?. J Antimicrob Chemother
54: 481-488
[Abstract]
[Full Text]
-
Garcia-Rey, C., Fenoll, A., Aguilar, L., Casal, J.
(2004). Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain. J Antimicrob Chemother
54: 465-471
[Abstract]
[Full Text]
-
Uh, Y., Jang, I. H., Hwang, G. Y., Lee, M. K., Yoon, K. J., Kim, H. Y.
(2004). Antimicrobial Susceptibility Patterns and Macrolide Resistance Genes of {beta}-Hemolytic Streptococci in Korea. Antimicrob. Agents Chemother.
48: 2716-2718
[Abstract]
[Full Text]
-
Croisier, D., Etienne, M., Bergoin, E., Charles, P.-E., Lequeu, C., Piroth, L., Portier, H., Chavanet, P.
(2004). Mutant Selection Window in Levofloxacin and Moxifloxacin Treatments of Experimental Pneumococcal Pneumonia in a Rabbit Model of Human Therapy. Antimicrob. Agents Chemother.
48: 1699-1707
[Abstract]
[Full Text]
-
Low, D. E., Pichichero, M. E., Schaad, U. B.
(2004). Optimizing Antibacterial Therapy for Community-Acquired Respiratory Tract Infections in Children in an Era of Bacterial Resistance. CLIN PEDIATR
43: 135-151
[Abstract]
-
Perez-Trallero, E., Marimon, J. M., Gonzalez, A., Garcia-Rey, C., Aguilar, L.
(2003). Genetic Relatedness of Recently Collected Spanish Respiratory Tract Streptococcus pneumoniae Isolates with Reduced Susceptibility to Amoxicillin. Antimicrob. Agents Chemother.
47: 3637-3639
[Abstract]
[Full Text]
-
Garau, J., Twynholm, M., Garcia-Mendez, E., Siquier, B., Rivero, A., the 557 Clinical Study Group,
(2003). Oral pharmacokinetically enhanced co-amoxiclav 2000/125 mg, twice daily, compared with co-amoxiclav 875/125 mg, three times daily, in the treatment of community-acquired pneumonia in European adults. J Antimicrob Chemother
52: 826-836
[Abstract]
[Full Text]
-
Martin-Herrero, J. E., Garcia-Rey, C., Dal-Re, R., Aguilar, L.
(2003). Clinical and bacteriological implications of macrolide resistance in group A streptococcal pharyngitis. J Antimicrob Chemother
52: 735-736
[Full Text]
-
Jacobs, M. R., Felmingham, D., Appelbaum, P. C., Gruneberg, R. N., the Alexander Project Group,
(2003). The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother
52: 229-246
[Abstract]
[Full Text]
-
Balsalobre, L., Ferrandiz, M. J., Linares, J., Tubau, F., de la Campa, A. G.
(2003). Viridans Group Streptococci Are Donors in Horizontal Transfer of Topoisomerase IV Genes to Streptococcus pneumoniae. Antimicrob. Agents Chemother.
47: 2072-2081
[Abstract]
[Full Text]
-
Alberti, S., Garcia-Rey, C., Dominguez, M. A., Aguilar, L., Cercenado, E., Gobernado, M., Garcia-Perea,, A.
(2003). Survey of emm Gene Sequences from Pharyngeal Streptococcus pyogenes Isolates Collected in Spain and Their Relationship with Erythromycin Susceptibility. J. Clin. Microbiol.
41: 2385-2390
[Abstract]
[Full Text]
-
Decousser, J.-W., Pina, P., Picot, F., Delalande, C., Pangon, B., Courvalin, P., Allouch, P., the ColBVH study group,
(2003). Frequency of isolation and antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections: a French prospective national survey. J Antimicrob Chemother
51: 1213-1222
[Abstract]
[Full Text]
-
de la Campa, A. G., Ferrandiz, M.-J., Tubau, F., Pallares, R., Manresa, F., Linares, J.
(2003). Genetic Characterization of Fluoroquinolone-Resistant Streptococcus pneumoniae Strains Isolated during Ciprofloxacin Therapy from a Patient with Bronchiectasis. Antimicrob. Agents Chemother.
47: 1419-1422
[Abstract]
[Full Text]
-
Dobay, O., Rozgonyi, F., Hajdu, E., Nagy, E., Knausz, M., Amyes, S. G. B.
(2003). Antibiotic susceptibility and serotypes of Streptococcus pneumoniae isolates from Hungary. J Antimicrob Chemother
51: 887-893
[Abstract]
[Full Text]
-
Danesi, R., Lupetti, A., Barbara, C., Ghelardi, E., Chella, A., Malizia, T., Senesi, S., Angeletti, C. A., Del Tacca, M., Campa, M.
(2003). Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg. J Antimicrob Chemother
51: 939-945
[Abstract]
[Full Text]
-
Reinert, R. R., Lutticken, R., Bryskier, A., Al-Lahham, A.
(2003). Macrolide-Resistant Streptococcus pneumoniae and Streptococcus pyogenes in the Pediatric Population in Germany during 2000-2001. Antimicrob. Agents Chemother.
47: 489-493
[Abstract]
[Full Text]
-
Alos, J. I., Aracil, B., Oteo, J., Gomez-Garces, J. L., the Spanish Group for the Study of Infection in th,
(2003). Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain. J Antimicrob Chemother
51: 333-337
[Abstract]
[Full Text]
-
Croisier, D., Chavanet, P., Lequeu, C., Ahanou, A., Nierlich, A., Neuwirth, C., Piroth, L., Duong, M., Buisson, M., Portier, H.
(2002). Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones. J Antimicrob Chemother
50: 349-360
[Abstract]
[Full Text]
-
Latorre, C., Garcia-Rey, C., Garcia-Perea, A., Perea, E., Aguilar, L., Cercenado, E., Garcia-de-Lomas, J., the Spanish Surveillance Group for Respiratory Pat,
(2002). Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin. J Antimicrob Chemother
50: 301-303
[Full Text]
-
Perez-Trallero, E., Garcia-Rey, C., Martin-Sanchez, A. M., Aguilar, L., Garcia-de-Lomas, J., Ruiz, J.
(2002). Activities of Six Different Quinolones against Clinical Respiratory Isolates of Streptococcus pneumoniae with Reduced Susceptibility to Ciprofloxacin in Spain. Antimicrob. Agents Chemother.
46: 2665-2667
[Abstract]
[Full Text]
-
Pankuch, G. A., Bozdogan, B., Nagai, K., Tambic-Andrasevic, A., Schoenwald, S., Tambic, T., Kalenic, S., Plesko, S., Tepes, N. K., Kotarski, Z., Payerl-Pal, M., Appelbaum, P. C.
(2002). Incidence, Epidemiology, and Characteristics of Quinolone- Nonsusceptible Streptococcus pneumoniae in Croatia. Antimicrob. Agents Chemother.
46: 2671-2675
[Abstract]
[Full Text]
-
Garcia-Rey, C., Aguilar, L., Baquero, F., Casal, J., Martin, J. E.
(2002). Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain. J. Clin. Microbiol.
40: 2959-2963
[Abstract]
[Full Text]
-
Low, D. E., de Azavedo, J., Weiss, K., Mazzulli, T., Kuhn, M., Church, D., Forward, K., Zhanel, G., Simor, A., McGeer, A.
(2002). Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob. Agents Chemother.
46: 1295-1301
[Abstract]
[Full Text]
-
Garcia-Rey, C., Aguilar, L., Baquero, F., Casal, J., Dal-Re, R.
(2002). Importance of Local Variations in Antibiotic Consumption and Geographical Differences of Erythromycin and Penicillin Resistance in Streptococcus pneumoniae. J. Clin. Microbiol.
40: 159-164
[Abstract]
[Full Text]